Larimar Therapeutics LRMR
NASDAQ LRMR
$2.42 -0.02 (-0.82%)
At close: Oct 21, 2026 · 4:00 PM EDT

Larimar Therapeutics (LRMR) Long-Term Debt Issuances (2014)

Updated

Larimar Therapeutics' Long-Term Debt Issuances came in at $20 million for FY2017.

Analysis

Larimar Therapeutics (LRMR) Long-Term Debt Issuances (2014) Analysis & Trends

  • Long-Term Debt Issuances carries a five-year compound annual growth rate of 27.3% (FY2012 to FY2017).
  • The FY2017 figure represents the lowest annual Long-Term Debt Issuances since FY2014.
  • Per Business Quant, earlier years put Long-Term Debt Issuances at $7.39 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Larimar Therapeutics 252.95 Mn -354.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 10,000.00
Mar 31, 2014 7.38 Mn
API Access

Larimar Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=LRMR&period=max&api_key=YOUR_API_KEY